ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Coalition to Congress: ‘Find a Way To Fund The War,’ Bypass Level Is Not Enough

August 7, 1992

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Totality Of Evidence Causes Concern About New Findings.

December 7, 2007

HCT Survivors More Likely To Show Heart Disease Risk Factors

October 26, 2012

DCPC Advisers Ok Four New Grant Programs To Foster Prevention

May 22, 1992